http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2448701-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_558bef486783b0ad8cc32c021cdc1650 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ea215b487a30e736840d0a95ebca196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_686736447cba52f6bf77aa2118130e8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ceeac938e56fdab4bf10f865d884bce |
publicationDate | 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2448701-C2 |
titleOfInvention | Pharmaceutical composition for treating and/or preventing arterial hypertension |
abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: there is offered a pharmaceutical composition for treating and/or preventing arterial hypertension containing an angiotensin converting enzyme (ACE) inhibitor and N-acetyl-5-methoxytriptamine (melatonin) in the following proportions: ACE inhibitor - 2-4; N-acetyl-5-methoxytriptamine (melatonin) - 2-8; excipients - up to 100 mg with the ACE inhibitor being presented by the compounds specified in a group of enalapril, captopril, perindopril, lisinopril, fozinopril, quinapril, spirapril. The pharmaceutical composition may be presented by a solid dosage form - a tablet, a film-coated tablet, a softgel capsule, a solid gel capsule, by a soft dosage form - a rectal suppositorium. n EFFECT: providing a therapeutically significant effect (stable night-time blood pressure profile) and a lower risk of side effects due to using the doses low for the ACE inhibitors specified above have been shown. n 3 cl, 3 tbl |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2549940-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2497520-C1 |
priorityDate | 2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.